Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1986
http://purl.obolibrary.org/obo/NCIT_C1986
|
|---|---|
| Preferred Name | p53 Peptide Vaccine MPS-128 |
| Definitions |
A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein. (NCI04) |
|---|---|
| prefLabel | p53 Peptide Vaccine MPS-128
|
| label | p53 Peptide Vaccine MPS-128
|
| PDQ_Closed_Trial_Search_ID | 43633
|
| code | C1986
|
| Has_Target | |
| prefixIRI | NCIT:C1986
|
| in_subset | |
| Preferred_Name | p53 Peptide Vaccine MPS-128
|
| Maps_To | p53 Peptide Vaccine MPS-128
|
| NSC Number | 717111
|
| NCI_Drug_Dictionary_ID | 43633
|
| Legacy Concept Name | p53_Peptide_Vaccine
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 43633
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Immunologic Factor
|
| UMLS_CUI | C0879339
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |